loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 18082 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ABBVIE (1)

    filter

    01 SYRUP;ORAL (1)

    filter

    01 DISCN (1)

    filter

    01 DEPAKENE (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VALPROIC ACID

    PDF Supplier PDF
    URL Supplier Web Content
    SYRUP; ORAL
    250MG/5ML **Federa...
    1982-01-01
    18082
    DEPAKENE
    DISCN
    Yes
    Abbvie Company Banner

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 18082

    Looking for FDA Orange Book APPLICATION 18082 1

    19

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is VALPROIC ACID, with a corresponding application number 18082.

    Regulatory Information DISCN

    With a dosage strength 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Dosage Form Route SYRUP; ORAL

    Reference Listed Drug Yes

    Approved since 1982-01-01

    Post Enquiry
    POST ENQUIRY